Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non‐splenectomized patients
Massimo Federico(University of Modena and Reggio Emilia), V. Silingardi(Azienda Ospedaliero-Universitaria di Modena), Giovanni Capnist(Ospedale San Bortolo), G. Pagnucco, L Resegotti, Teodoro Chisesi(Ospedale Civile di Venezia), Antonio Frassoldati(Italian Oncology Group of Clinical Research), E Damasio(Istituto di Ematologia di Bologna), F. Lauria(Istituto di Ematologia di Bologna), Gianluigi Castoldi(University of Ferrara), Carlo Bernasconi(University Hospital Foundation)
Cited by 11
Related Papers
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
|Blood|2011|431
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|339